Matthew P. Miller - Nov 17, 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Operating Officer
Signature
By: Mark Hueppelsheuser For: Matt Miller
Stock symbol
TOI
Transactions as of
Nov 17, 2022
Transactions value $
$0
Form type
4
Date filed
11/21/2022, 04:33 PM
Previous filing
Nov 22, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +23.6K +30.25% $0.00 102K Nov 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Award $0 +120K $0.00 120K Nov 17, 2022 Common Stock 120K $1.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents RSUs with 1/4th of the RSUs vesting on the anniversary of November 17, 2022 (the Vesting Commencement Date), with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F2 The stock options vest as to 1/4th of the options granted on the first anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.